HLA associations with infliximab-induced liver injury
Christopher D. Bruno, Brandon Fremd, Rachel J. Church, Ann K. Daly, Guruprasad P. Aithal, Einar S. Björnsson, Dominique Larrey, Paul B. Watkins, Christina R. Chow
Topics & Concepts
InfliximabOdds ratioMedicineInternal medicineHuman leukocyte antigenHaplotypeAlleleConfidence intervalGastroenterologyLiver injuryImmunologyAntigenTumor necrosis factor alphaGeneticsBiologyGeneDrug-Induced Hepatotoxicity and ProtectionLiver Diseases and ImmunityHepatitis C virus research